News Teva plans migraine drug filing later this year Blockbuster hopeful could launch next year if approved.
News AZ sells migraine drug rights to Grunenthal for $300m AZ says migraine outside its strategic focus.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
